Scarica l'app Stockscreener
35.77
1.76%
0.62
Veracyte Inc Borsa (VCYT) Ultime notizie
Pharma News: What is the next catalyst for Veracyte IncJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - baoquankhu1.vn
Veracyte (NASDAQ:VCYT) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Is Veracyte Inc. exposed to currency risks2025 Valuation Update & Daily Profit Maximizing Trade Tips - mfd.ru
56,756 Shares in Veracyte, Inc. $VCYT Bought by Thrivent Financial for Lutherans - MarketBeat
Is Veracyte Inc.’s ROIC above industry averageTrade Volume Report & Free Community Consensus Stock Picks - mfd.ru
Can Veracyte Inc. expand into new marketsJuly 2025 Selloffs & Real-Time Buy Signal Notifications - mfd.ru
Why Veracyte Inc. stock is considered a top pickJuly 2025 Final Week & Reliable Entry Point Trade Alerts - mfd.ru
Veracyte, Inc. $VCYT Stock Holdings Increased by Allianz Asset Management GmbH - MarketBeat
Sentiment Watch: What are the future prospects of Veracyte Inc2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Is Veracyte (VCYT) Pricing Reflect Future Cash Flows After Multi Year Share Price Slide - Yahoo Finance
Federated Hermes Inc. Sells 52,039 Shares of Veracyte, Inc. $VCYT - MarketBeat
Principal Financial Group Inc. Boosts Stake in Veracyte, Inc. $VCYT - MarketBeat
IQ EQ FUND MANAGEMENT IRELAND Ltd Has $4.78 Million Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Sarepta Therapeutics (SRPT) and Viridian Therapeutics (VRDN) - The Globe and Mail
Veracyte (VCYT) Loses 20.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - BioSpace
Veracyte is Now Oversold (VCYT) - Nasdaq
Here's Why Veracyte (VCYT) is a Strong Growth Stock - Yahoo Finance
Aug Fed Impact: Can Veracyte Inc generate free cash flowJuly 2025 Earnings & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Veracyte’s Growth Story Hit A Valuation Wall - Finimize
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Hold" from Analysts - MarketBeat
Stock Report: Is Veracyte Inc stock a top performer YTD2025 Price Targets & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Improved Revenues Required Before Veracyte, Inc. (NASDAQ:VCYT) Shares Find Their Feet - 富途牛牛
Targets Report: What makes Veracyte Inc. stock attractive today2025 Major Catalysts & AI Powered Trade Plan Recommendations - baoquankhu1.vn
GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test - Nasdaq
Here's Why Veracyte (VCYT) Is a Great 'Buy the Bottom' Stock Now - Finviz
Reasons to Retain Avanos Medical Stock in Your Portfolio Now - Finviz
Can Veracyte Inc. ride the EV waveQuarterly Portfolio Report & Precise Buy Zone Identification - mfd.ru
Earnings Miss: Can Veracyte Inc expand into new marketsEarnings Summary Report & Fast Moving Market Watchlists - baoquankhu1.vn
Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader With 17.49% Potential Upside - DirectorsTalk Interviews
Why Veracyte (VCYT) is poised to beat earnings estimates again - MSN
Veracyte, Inc. (VCYT) sees analyst support as Guggenheim reaffirms buy rating - MSN
Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again - Prime Publishers, Inc.
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - MSN
Veracyte Inc. (NASDAQ:VCYT) Emerges as a Prime Affordable Growth Candidate - Chartmill
AEGON ASSET MANAGEMENT UK Plc Has $14.06 Million Stock Position in Veracyte, Inc. $VCYT - MarketBeat
Stronger‑Than‑Expected Revenue Outlook Might Change The Case For Investing In Veracyte (VCYT) - simplywall.st
Swing Trade: What is the dividend yield of TriSalus Life Sciences Inc Equity WarrantJuly 2025 WrapUp & Verified Entry Point Signals - baoquankhu1.vn
Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Assessing Veracyte (VCYT) Valuation As Recent Momentum Meets An Expensive P/E Ratio - Sahm
Is Veracyte’s (VCYT) Confident Double‑Digit Revenue Outlook Altering The Investment Case For Investors? - Yahoo Finance
Veracyte, Inc. (VCYT) Sees Analyst Support as Guggenheim Reaffirms Buy Rating - Finviz
Centene Expands Palliative Care Access in Ohio Through Tuesday Health - Nasdaq
QRG Capital Management Inc. Sells 106,926 Shares of Veracyte, Inc. $VCYT - MarketBeat
S P Trends: Is Veracyte Inc showing insider buyingTrade Entry Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
State of Alaska Department of Revenue Takes $1.50 Million Position in Veracyte, Inc. $VCYT - MarketBeat
Trade Recap: Is Veracyte Inc stock a value trapJuly 2025 PostEarnings & Risk Managed Trade Strategies - baoquankhu1.vn
Veracyte: Profitable, De-Risked, And Ready To Run (NASDAQ:VCYT) - Seeking Alpha
Sumitomo Mitsui Trust Group Inc. Sells 165,094 Shares of Veracyte, Inc. $VCYT - MarketBeat
SG Americas Securities LLC Increases Stock Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (NASDAQ:VCYT) Cut to Hold at Zacks Research - MarketBeat
Is Veracyte’s 2026 Growth Guidance And New US Launches Altering The Investment Case For Veracyte (VCYT)? - Sahm
0.00%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):